|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 229/38 | |
| C07C 317/22 | |||
| C07C 63/04 | |||
| C07C 257/00 | |||
| C07D 333/22 | |||
| C07D 307/02 | |||
| C07D 277/30 | |||
| C07D 207/30 | |||
| C07D 207/08 | |||
| C07D 211/70 | |||
| C07D 311/78 | |||
| A61K 31/192 | |||
| A61K 31/341 | |||
| A61P 7/00 |
| (11) | Number of the document | 1383731 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01981772.5 |
| Date of filing the European patent application | 2001-10-22 | |
| (97) | Date of publication of the European application | 2004-01-28 |
| (45) | Date of publication and mention of the grant of the patent | 2009-08-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2001/032582 |
| Date | 2001-10-22 |
| (87) | Number | WO 2002/034711 |
| Date | 2002-05-02 |
| (30) | Number | Date | Country code |
| 281735 P | 2001-04-06 | US |
| (72) |
BABU, Yarlagadda, S., US
ROWLAND, Scott, R., US
CHAND, Pooran, US
KOTIAN, Pravin, L., US
EL-KATTAN, Yahya, US
NIWAS, Shri, US
|
| (73) |
BIOCRYST PHARMACEUTICALS, INC.,
2910 Parkway Lake Drive, Birmingham, Alabama 35244,
US
|
| (54) | BIARYL COMPOUNDS AS SERINE PROTEASE INHIBITORS |
| BIARYL COMPOUNDS AS SERINE PROTEASE INHIBITORS |